Announcement That U Albany's Cancer Research Center (Crc) And St. Peter's Hospital Will Partner In Prostate Cancer Drug Research
2007 July 6
Announcement that UAlbany's Cancer Research Center (CRC) and St. Peter's Hospital will partner in prostate cancer drug research. Scott Tanenbaum, molecular geneticist at the CRC, and Dr. Michael Perrotti, MD, a urologic oncologist of St. Peters, will lead the research project into the effectiveness of the drug dutasteride on treating men with prostate cancer. The research will be funded by a grant from the Dominic Ferraioli Foundation.
Subjects
Source Details
News release, "UAlbany Cancer Center and St. Peter's Hospital Partner for Prostate Cancer Drug Research," August 6, 2007, UAlbany News Archive, Office of Communications and Marketing